featured
Cinpanemab for Early-Stage Parkinson's Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Trial of Cinpanemab in Early Parkinson's Disease
N. Engl. J. Med 2022 Aug 04;387(5)408-420, AE Lang, AD Siderowf, EA Macklin, W Poewe, DJ Brooks, HH Fernandez, O Rascol, N Giladi, F Stocchi, CM Tanner, RB Postuma, DK Simon, E Tolosa, B Mollenhauer, JM Cedarbaum, K Fraser, J Xiao, KC Evans, DL Graham, I Sapir, J Inra, RM Hutchison, M Yang, T Fox, S Budd Haeberlein, T DamFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.